Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2012
05/10/2012WO2012016145A3 Mitochondrial apoptosis-induced inflammation
05/10/2012WO2012015975A3 Glp-1 receptor agonist compounds having stabilized regions
05/10/2012WO2012012656A3 Materials and methods for treating neurodegenerative diseases
05/10/2012WO2012007658A4 Use of the pat nonapeptide in treating and preventing neurodegenerative diseases
05/10/2012WO2012006149A3 Analogs of c5a and methods of using same
05/10/2012WO2011163649A3 Methods and compositions for cns delivery of iduronate-2-sulfatase
05/10/2012WO2011163647A3 Methods and compositions for cns delivery of heparan n-sulfatase
05/10/2012WO2011156729A3 Methods of mitigating effects of radiation and reducing the risk of systemic infection
05/10/2012WO2011156715A3 Methods of treating metabolic disorders and cardiovascular diseases
05/10/2012WO2011139854A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
05/10/2012WO2011139853A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
05/10/2012WO2011128631A3 Vegetarian oral pharmaceutical and nutraceutical compositions
05/10/2012WO2011120904A3 A fast dissolving pharmaceutical composition
05/10/2012WO2011116286A4 Stable bortezomib formulations
05/10/2012WO2011110359A8 Stat3 activation inhibitors
05/10/2012WO2011060018A3 Compositions and methods for using peptides, modified peptides, peptidomimetics and fibrin derivatives
05/10/2012WO2010144789A3 Diketopiperazine microparticles with defined specific surface areas
05/10/2012US20120117672 Isolation and growth of stem cells from hemangiomas
05/10/2012US20120117669 Human antibodies derived from immunized xenomice
05/10/2012US20120116052 Nucleic Acid Molecules Encoding TNF-Alpha Ligand Polypeptides Having a CD154 Domain
05/10/2012US20120115950 Abuse-resistant amphetamine prodrugs
05/10/2012US20120115797 Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same
05/10/2012US20120115796 Novel Spacer Moiety for Poly(ehtylene Glycol) Modified Peptide Based Compounds
05/10/2012US20120115795 Regulation of Sodium Channels by PLUNC Proteins
05/10/2012US20120115794 Use of cd44v6 in the treatment of ophthalmic diseases
05/10/2012US20120115793 Peptidomimetic macrocycles
05/10/2012US20120115791 Methods for Treating Immune Mediated Neurological Diseases
05/10/2012US20120115790 Therapeutic approach to neurodegenerative disorders using a tfp5-peptide
05/10/2012US20120115789 Methylglyoxal-Scavenging Compounds and Their Use for the Prevention and Treatment of Pain and/or Hyperalgesia
05/10/2012US20120115788 Use of liposomal WNT composition to enhance Osseointegration
05/10/2012US20120115787 Sclerostin and the inhibition of WNT signaling and bone formation
05/10/2012US20120115786 Agent for reducing risk in onset of disease ascribable to non-dipper circadian rhythm of blood pressure
05/10/2012US20120115785 Endothelial nitric oxide synthase antagonists and uses thereof for inhibiting oxygen toxicity
05/10/2012US20120115784 Assessment of Cardiac Health and Thrombotic Risk in a Patient
05/10/2012US20120115783 Peptidomimetic macrocycles
05/10/2012US20120115782 Compositions and methods for treating or inhibiting liver injury
05/10/2012US20120115781 Methods For Evaluating and Implementing Prostate Disease Treatments
05/10/2012US20120115780 Porogen Containing Calcium Phosphate Cement Compositions
05/10/2012US20120115779 Agent for suppressing elevation of blood triglyceride concentration
05/10/2012US20120115778 Methods of Suppressing Appetite by the Administration of Antagonists of the Serotonin HTR1a or HTR2b Receptors or Inhibitors of TPH2
05/10/2012US20120115777 Use of Ultrarapid Acting Insulin
05/10/2012US20120115776 Adiponectin-containing eating behavior control agent for oral administration
05/10/2012US20120115775 Mutant tat proteins and uses thereof
05/10/2012US20120115774 Antimicrobial cationic lipo-beta-peptides
05/10/2012US20120115773 Modified omci as a complement inhibitor
05/10/2012US20120115772 Conjugation method
05/10/2012US20120115771 Carrier
05/10/2012US20120115746 Compositions and methods for treating and diagnosing irritable bowel syndrome
05/10/2012US20120115162 Anti-fatty acid amide hydrolase-2 antibodies and uses thereof
05/10/2012US20120115136 Pna diagnostic use
05/10/2012US20120114776 Methods for preparing probiotic nanoparticles
05/10/2012US20120114765 Anti-neoplastic compounds, compositions and methods
05/10/2012US20120114759 Peptide/particle delivery systems
05/10/2012US20120114745 Method for treating or ameliorating mucocutaneous or ocular toxicities
05/10/2012US20120114742 Polymer Conjugates with Decreased Antigenicity, Methods of Preparation and Uses Thereof
05/10/2012US20120114739 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
05/10/2012US20120114737 Silicone acrylate hybrid composition and method of making same
05/10/2012US20120114734 Nanostructure surface coated medical implants and methods of using the same
05/10/2012US20120114731 Multilayer protein films, methods of making, and drug delivery devices and biomedical implants employing the films
05/10/2012US20120114730 Compositions and methods for treating precocious puberty
05/10/2012US20120114709 Formulations for use in inhaler devices
05/10/2012US20120114708 Integrin heterodimer and an alpha subunit thereof
05/10/2012US20120114707 Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein
05/10/2012US20120114706 Endorphin Therapy Compositions and Methods of Use Thereof
05/10/2012US20120114703 Botulinum Toxin Administration to Treat Various Conditions
05/10/2012US20120114700 Lat adapter molecule for enhanced t-cell signaling and method of use
05/10/2012US20120114693 Nucleic acid mucosal immunization
05/10/2012US20120114690 External use composition for skin
05/10/2012US20120114684 Compounds and methods for treatment and diagnosis of chlamydial infection
05/10/2012US20120114682 Peptides for binding fibrinogen and fibrin
05/10/2012US20120114681 Use of specific peptides in the preparation of a medicament for the treatment of monoclonal gammopathy of undetermined significance (mgus) or of smoldering multiple myeloma (smm)
05/10/2012US20120114679 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/10/2012US20120114676 Methods of treating cancer with phenformin
05/10/2012US20120114674 Molecular Antigen Array
05/10/2012US20120114670 Methods and compositions related to synergistic responses to oncogenic mutations
05/10/2012US20120114669 Compositions and method for the diagnosis, prevention and treatment of alzheimer's disease
05/10/2012US20120114668 Method for modulating angiogenesis using fibromodulin
05/10/2012US20120114667 TARGETED BINDING AGENTS DIRECTED TO a5BETA1 AND USES THEREOF
05/10/2012US20120114666 Neurological autoimmune disorders
05/10/2012US20120114663 Methods to treat allergic conditions
05/10/2012US20120114660 Antibodies Against LLG Polypeptides of the Triacylglycerol Lipase Family
05/10/2012US20120114655 Xylan utilization regulon for efficient bioprocessing of hemicellulose and uses thereof
05/10/2012US20120114641 Therapeutic combination comprising a plk1 inhibitor and an antineoplastic agent
05/10/2012US20120114633 Inhibitors Of Bacterial Type III Secretion System
05/10/2012US20120114631 Stable enzymatic preparations and methods of use thereof
05/10/2012US20120114630 Variants of plasminogen and plasmin
05/10/2012US20120114629 Iga1 protease polypeptide agents and uses thereof
05/10/2012US20120114628 Cosmetic and therapeutic use of proteins of dj-1 type for treating skin dryness
05/10/2012US20120114627 Diagnosis, prevention and treatment of disorders characterized by undesirable cell proliferation
05/10/2012US20120114626 Method for treating pervasive development disorders
05/10/2012US20120114625 Shelf-stable fermented dairy products and methods of making same
05/10/2012US20120114619 Protein with promoting effects for axonal growth of neurons of central nervous system
05/10/2012US20120114617 Peptide promoting cell adhesion and migration
05/10/2012US20120114615 Hydrolytically degradable polysaccharide hydrogels
05/10/2012US20120114605 Methods and compositions relating to hematologic malignancies
05/10/2012US20120114604 Combinations for HCV Treatment
05/10/2012US20120114603 Ifn-alpha/beta-independent mechanism of antiviral protection through a novel ligand-receptor pair: ifn- ligands engage a novel receptor ifn-rn (crf2-12) and il-10r2 (crf2-4) for signaling andinduction of biological activities
05/10/2012US20120114602 Process for the synthesis of conjugates of glycosaminoglycanes (gag) with biologically active molecules, polymeric conjugates and relative uses thereof
05/10/2012US20120114601 New isothiazoloquinolones and related compounds as anti-infective agents
05/10/2012US20120114600 Novel inhibitors of hepatitis c virus
1 ... 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 ... 3163